Drugs, Key Data 2013

 

DCC2013en.jpg

OFDT, 8 p.
June 2013

The purpose of this publication is to periodically collect the most recent and most relevant key quantitative indicators of drug use, whether illegal substances, tobacco, alcohol or psychotropic medicines. These data constitute a common foundation of knowledge on which public authority actions are based, coordinated by the French Interministerial Mission for the Fight against Drugs and Drug Addiction (MILDT) placed under the authority of the Prime Minister.

This document, prepared by the French Monitoring Centre for Drugs and Drug Addiction (OFDT), relies on its own research as well as the work of other institutions. First and foremost, it summarises for the main substances the levels of use observed in the French population as a whole. Then, it provides detailed information on use, treatment, health and social consequences as well as trafficking data per product. When possible, trends in these areas are provided.

Download the PDF file (146 Ko)
Lire la version originale en français

Drugs in Europe

2016 EMCDDA European Drug Report

- Drug facts, figures and analyses: across Europe and by country
- Latest trends and legal, political and social responses
- Selected issues: Vulnerable groups of young people; National drug-related research in Europe; Towards a better understanding of drug-related public expenditure in Europe

Country situation summaries

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) website has a concise overview for each EU Member State on their national drug situation, as well as legal texts in their original formats, an indispensable tool for monitoring and analysing legislative developments in the Member States.

The European Union and the drug phenomenon

The European Union & the drug phenomenon : Frequently asked questions , joint publication between the EMCDDA and the European Commission, october 2010, 12 p.